An AI tool analyzing CCTA images can predict future cardiovascular events and death in patients with suspected stable coronary artery disease.
Key Details
- 1The FISH&CHIPS study involved 7,836 patients who underwent AI-derived FFR-CT analysis from an initial 90,553 receiving CCTA.
- 2Lower FFR-CT values correlated with significantly increased rates of MI, cardiovascular death, and all-cause mortality independent of traditional risk factors.
- 3Patients with severely reduced FFR-CT had a four-fold risk of heart attack and triple risk of death versus those with normal values.
- 4The FFR-CT AI analysis (by HeartFlow) provided additive prognostic value over classical cardiovascular risk scores.
- 5This is the first large-scale evidence of FFR-CT's independent prognostic power in stable CAD.
- 6Study funded by UK MRC; HeartFlow provided analysis but did not fund or direct the study.
Why It Matters
This research demonstrates real-world prognostic utility for AI-based imaging tools in cardiovascular risk prediction, supporting expanded adoption of AI-enhanced CT in personalized patient management and reducing unnecessary procedures.
Source
EurekAlert
Related News
•EurekAlert
AI Tool from UCLA Targets Undiagnosed Alzheimer's and Diagnostic Disparity
UCLA researchers developed an AI model using EHR data to better detect undiagnosed Alzheimer's disease, especially in underrepresented groups.
•EurekAlert
AI Multimodal Models Improve Breast Cancer Recurrence Risk Prediction
Initial results from an ECOG-ACRIN and Caris Life Sciences collaboration show AI-driven multimodal models can more accurately predict recurrence risk in early-stage breast cancer.
•EurekAlert
AI Model Improves Differentiation of Brain Tumor Progression from Radiation Necrosis on MRI
A York University-led study shows a novel AI using advanced MRI can distinguish between progressive brain tumors and radiation necrosis more accurately than human assessment.